Thymic age and peripheral residence time determine antitumor competence of CD8+ T cells.
These findings establish developmental imprinting as an important determinant of CD8+ T cell heterogeneity and identify CXCR3+IL-18Rα+ CD8+ T cells as key effectors for antitumor immunity.